{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T11:02:36Z","timestamp":1794740556883,"version":"4.9.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Blood Cancer J."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    GATA2 deficiency is an autosomal dominant transcriptopathy disorder with high risk for myelodysplastic syndrome (MDS). To elucidate genotype-phenotype associations and identify new genetic risk factors for MDS, we analyzed 218 individuals with germline heterozygous\n                    <jats:italic>GATA2<\/jats:italic>\n                    variants. We observed striking age-dependent incidence patterns in GATA2-related MDS (GATA2-MDS), with MDS being absent in infants, rare before age 6 years, and steeply increasing in older children. Among 108 distinct\n                    <jats:italic>GATA2<\/jats:italic>\n                    variants (67 novel), null mutations conferred a 1.7-fold increased risk for MDS, had earlier MDS onset compared to other variants (12.2 vs. 14.6 years,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.009) and were associated with lymphedema and deafness. In contrast, intron 4 variants exhibited reduced penetrance and lower risk for MDS development. Analysis of the somatic landscape revealed unique patterns of clonal hematopoiesis.\n                    <jats:italic>SETBP1<\/jats:italic>\n                    mutations occurred exclusively in patients with monosomy 7 and their frequency decreased with age. Conversely, the frequency of\n                    <jats:italic>STAG2<\/jats:italic>\n                    mutations and trisomy 8 increased with age and appeared protective against early development of advanced MDS. Overall, the majority (73.9%) of mutation-positive cases harbored monosomy 7, suggesting it serves as a major driver in malignant progression. Our findings provide evidence for age-appropriate surveillance, and a foundation for genotype-driven risk stratification in GATA2 deficiency.\n                  <\/jats:p>","DOI":"10.1038\/s41408-025-01309-6","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T08:10:54Z","timestamp":1752567054000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Age-dependent phenotypic and molecular evolution of pediatric MDS arising from GATA2 deficiency"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5089-7659","authenticated-orcid":false,"given":"Lili","family":"Kotmayer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia J.","family":"Kozyra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6102-0115","authenticated-orcid":false,"given":"Guolian","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Strahm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1593-9507","authenticated-orcid":false,"given":"Ayami","family":"Yoshimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushree S.","family":"Sahoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor B.","family":"Pastor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Attardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-0696-439X","authenticated-orcid":false,"given":"Rebecca","family":"Voss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7685-5355","authenticated-orcid":false,"given":"Luca","family":"Vinci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Kaiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael N.","family":"Dworzak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2449-539X","authenticated-orcid":false,"given":"Barbara","family":"De Moerloose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Sukova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Star\u00fd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3976-9231","authenticated-orcid":false,"given":"Henrik","family":"Hasle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9296-2028","authenticated-orcid":false,"given":"Kirsi","family":"Jahnukainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Polychronopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kriszti\u00e1n","family":"K\u00e1llay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Owen P.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Malone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shlomit","family":"Barzilai Birenboim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1264-057X","authenticated-orcid":false,"given":"Riccardo","family":"Masetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5848-4501","authenticated-orcid":false,"given":"Jochen","family":"Buechner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5725-4835","authenticated-orcid":false,"given":"Marek","family":"Ussowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5526-5565","authenticated-orcid":false,"given":"Paula","family":"Kj\u00f6llerstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana","family":"Bodova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marko","family":"Kavcic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Catal\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-0386-0714","authenticated-orcid":false,"given":"Dominik","family":"Turkiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4745-8572","authenticated-orcid":false,"given":"Markus","family":"Schmugge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"de Haas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3849-112X","authenticated-orcid":false,"given":"Victoria I.","family":"Okhomina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5847-5899","authenticated-orcid":false,"given":"Cristian","family":"Sotomayor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Catal\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5037-6175","authenticated-orcid":false,"given":"Claudia","family":"Wehr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Salzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Germing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Gattermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Csaba","family":"B\u00f6d\u00f6r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8030-9670","authenticated-orcid":false,"given":"Nathan","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Shimamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5803-3567","authenticated-orcid":false,"given":"Alessandra","family":"Giorgetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Erlacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3856-7937","authenticated-orcid":false,"given":"Charlotte M.","family":"Niemeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6638-9643","authenticated-orcid":false,"given":"Marcin W.","family":"Wlodarski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,15]]},"reference":[{"key":"1309_CR1","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1038\/ng.913","volume":"43","author":"CN Hahn","year":"2011","unstructured":"Hahn CN, Chong CE, Carmichael CL, Wilkins EJ, Brautigan PJ, Li XC et al. Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia. Nat Genet. 2011;43:1012\u20137.","journal-title":"Nat Genet"},{"key":"1309_CR2","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.1182\/blood-2011-05-356352","volume":"118","author":"AP Hsu","year":"2011","unstructured":"Hsu AP, Sampaio EP, Khan J, Calvo KR, Lemieux JE, Patel SY et al. Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome. Blood. 2011;118:2653\u20135.","journal-title":"Blood"},{"key":"1309_CR3","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1038\/ng.923","volume":"43","author":"P Ostergaard","year":"2011","unstructured":"Ostergaard P, Simpson MA, Connell FC, Steward CG, Brice G, Woollard WJ et al. Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome). Nat Genet. 2011;43:929\u201331.","journal-title":"Nat Genet"},{"key":"1309_CR4","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1182\/blood-2012-08-447367","volume":"121","author":"M Pasquet","year":"2013","unstructured":"Pasquet M, Bellanne-Chantelot C, Tavitian S, Prade N, Beaupain B, Larochelle O et al. High frequency of GATA2 mutations in patients with mild chronic neutropenia evolving to MonoMac syndrome, myelodysplasia, and acute myeloid leukemia. Blood. 2013;121:822\u20139.","journal-title":"Blood"},{"key":"1309_CR5","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s12185-017-2285-2","volume":"106","author":"S Hirabayashi","year":"2017","unstructured":"Hirabayashi S, Wlodarski MW, Kozyra E, Niemeyer CM. Heterogeneity of GATA2-related myeloid neoplasms. Int J Hematol. 2017;106:175\u201382.","journal-title":"Int J Hematol"},{"key":"1309_CR6","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1002\/humu.24271","volume":"42","author":"CC Homan","year":"2021","unstructured":"Homan CC, Venugopal P, Arts P, Shahrin NH, Feurstein S, Rawlings L et al. GATA2 deficiency syndrome: A decade of discovery. Hum Mutat. 2021;42:1399\u2013421.","journal-title":"Hum Mutat"},{"key":"1309_CR7","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.3324\/haematol.2017.181909","volume":"103","author":"J Donadieu","year":"2018","unstructured":"Donadieu J, Lamant M, Fieschi C, de Fontbrune FS, Caye A, Ouachee M et al. Natural history of GATA2 deficiency in a survey of 79 French and Belgian patients. Haematologica. 2018;103:1278\u201387.","journal-title":"Haematologica"},{"key":"1309_CR8","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.3324\/haematol.2022.282250","volume":"108","author":"L Largeaud","year":"2023","unstructured":"Largeaud L, Collin M, Monselet N, Vergez F, Fregona V, Larcher L et al. Somatic genetic alterations predict hematological progression in GATA2 deficiency. Haematologica. 2023;108:1515\u201329.","journal-title":"Haematologica"},{"key":"1309_CR9","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/s41588-023-01640-3","volume":"56","author":"M Umeda","year":"2024","unstructured":"Umeda M, Ma J, Westover T, Ni Y, Song G, Maciaszek JL et al. A new genomic framework to categorize pediatric acute myeloid leukemia. Nat Genet. 2024;56:281\u201393.","journal-title":"Nat Genet"},{"key":"1309_CR10","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1182\/blood-2015-09-669937","volume":"127","author":"MW Wlodarski","year":"2016","unstructured":"Wlodarski MW, Hirabayashi S, Pastor V, Star\u00fd J, Hasle H, Masetti R et al. Prevalence, clinical characteristics, and prognosis of GATA2-related myelodysplastic syndromes in children and adolescents. Blood. 2016;127:1387\u201397.","journal-title":"Blood"},{"key":"1309_CR11","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1038\/s41591-021-01511-6","volume":"27","author":"SS Sahoo","year":"2021","unstructured":"Sahoo SS, Pastor VB, Goodings C, Voss RK, Kozyra EJ, Szvetnik A et al. Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9\/SAMD9L syndromes. Nat Med. 2021;27:1806\u201317.","journal-title":"Nat Med"},{"key":"1309_CR12","doi-asserted-by":"publisher","first-page":"2656","DOI":"10.1182\/blood-2011-06-360313","volume":"118","author":"RE Dickinson","year":"2011","unstructured":"Dickinson RE, Griffin H, Bigley V, Reynard LN, Hussain R, Haniffa M et al. Exome sequencing identifies GATA-2 mutation as the cause of dendritic cell, monocyte, B and NK lymphoid deficiency. Blood. 2011;118:2656\u20138.","journal-title":"Blood"},{"key":"1309_CR13","doi-asserted-by":"publisher","first-page":"3830","DOI":"10.1182\/blood-2012-08-452763","volume":"121","author":"AP Hsu","year":"2013","unstructured":"Hsu AP, Johnson KD, Falcone EL, Sanalkumar R, Sanchez L, Hickstein DD et al. GATA2 haploinsufficiency caused by mutations in a conserved intronic element leads to MonoMAC syndrome. Blood. 2013;121:3830\u20137.","journal-title":"Blood"},{"key":"1309_CR14","doi-asserted-by":"publisher","first-page":"2833","DOI":"10.1084\/jem.20130733","volume":"210","author":"X Gao","year":"2013","unstructured":"Gao X, Johnson KD, Chang YI, Boyer ME, Dewey CN, Zhang J et al. Gata2 cis-element is required for hematopoietic stem cell generation in the mammalian embryo. J Exp Med. 2013;210:2833\u201342.","journal-title":"J Exp Med"},{"key":"1309_CR15","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1182\/blood.V130.Suppl_1.7.7","volume":"130","author":"C Mehta","year":"2017","unstructured":"Mehta C, Johnson KD, Gao X, Ong I, Katsumura KR, McIver SC et al. Integrating Enhancer Mechanisms to Establish a Hierarchical Blood Development Program. Blood. 2017;130:7.","journal-title":"Blood"},{"key":"1309_CR16","doi-asserted-by":"publisher","first-page":"3692","DOI":"10.1172\/JCI61623","volume":"122","author":"KD Johnson","year":"2012","unstructured":"Johnson KD, Hsu AP, Ryu MJ, Wang J, Gao X, Boyer ME et al. Cis-element mutated in GATA2-dependent immunodeficiency governs hematopoiesis and vascular integrity. J Clin Invest. 2012;122:3692\u2013704.","journal-title":"J Clin Invest"},{"key":"1309_CR17","doi-asserted-by":"publisher","first-page":"6351","DOI":"10.1182\/bloodadvances.2023010458","volume":"7","author":"RR West","year":"2023","unstructured":"West RR, Bauer TR, Tuschong LM, Embree LJ, Calvo KR, Tillo D et al. A novel GATA2 distal enhancer mutation results in MonoMAC syndrome in 2 second cousins. Blood Adv. 2023;7:6351\u201363.","journal-title":"Blood Adv"},{"key":"1309_CR18","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1053\/j.seminhematol.2017.05.002","volume":"54","author":"M Wlodarski","year":"2017","unstructured":"Wlodarski M, Collin M, Horwitz MS. GATA2 deficiency and related myeloid neoplasms. Semin Hematol. 2017;54:81\u201386.","journal-title":"Semin Hematol"},{"key":"1309_CR19","doi-asserted-by":"publisher","first-page":"4584","DOI":"10.1182\/bloodadvances.2020002953","volume":"4","author":"EH Bresnick","year":"2020","unstructured":"Bresnick EH, Jung MM, Katsumura KR. Human GATA2 mutations and hematologic disease: how many paths to pathogenesis? Blood Adv. 2020;4:4584\u201392.","journal-title":"Blood Adv"},{"key":"1309_CR20","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1182\/blood-2013-07-515528","volume":"123","author":"MA Spinner","year":"2014","unstructured":"Spinner MA, Sanchez LA, Hsu AP, Shaw PA, Zerbe CS, Calvo KR et al. GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity. Blood. 2014;123:809\u201321.","journal-title":"Blood"},{"key":"1309_CR21","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1182\/blood-2011-08-374363","volume":"119","author":"J Kazenwadel","year":"2012","unstructured":"Kazenwadel J, Secker GA, Liu YJ, Rosenfeld JA, Wildin RS, Cuellar-Rodriguez J et al. Loss-of-function germline GATA2 mutations in patients with MDS\/AML or MonoMAC syndrome and primary lymphedema reveal a key role for GATA2 in the lymphatic vasculature. Blood. 2012;119:1283\u201391.","journal-title":"Blood"},{"key":"1309_CR22","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1007\/s10875-023-01583-8","volume":"43","author":"S Roncareggi","year":"2023","unstructured":"Roncareggi S, Girardi K, Fioredda F, Pedace L, Arcuri L, Badolato R et al. A Nationwide Study of GATA2 Deficiency in Italy Reveals Novel Symptoms and Genotype-phenotype Association. J Clin Immunol. 2023;43:2192\u2013207.","journal-title":"J Clin Immunol"},{"key":"1309_CR23","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1038\/s41375-020-0899-5","volume":"34","author":"EJ Kozyra","year":"2020","unstructured":"Kozyra EJ, Pastor VB, Lefkopoulos S, Sahoo SS, Busch H, Voss RK et al. Synonymous GATA2 mutations result in selective loss of mutated RNA and are common in patients with GATA2 deficiency. Leukemia. 2020;34:2673\u201387.","journal-title":"Leukemia"},{"key":"1309_CR24","doi-asserted-by":"publisher","first-page":"890","DOI":"10.3324\/haematol.2011.054361","volume":"97","author":"C Bodor","year":"2012","unstructured":"Bodor C, Renneville A, Smith M, Charazac A, Iqbal S, Etancelin P et al. Germ-line GATA2 p.THR354MET mutation in familial myelodysplastic syndrome with acquired monosomy 7 and ASXL1 mutation demonstrating rapid onset and poor survival. Haematologica. 2012;97:890\u20134.","journal-title":"Haematologica"},{"key":"1309_CR25","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.hoc.2018.04.007","volume":"32","author":"MW Wlodarski","year":"2018","unstructured":"Wlodarski MW, Sahoo SS, Niemeyer CM. Monosomy 7 in Pediatric Myelodysplastic Syndromes. Hematol Oncol Clin North Am. 2018;32:729\u201343.","journal-title":"Hematol Oncol Clin North Am"},{"key":"1309_CR26","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1182\/blood.2021012781","volume":"138","author":"EJ Kozyra","year":"2021","unstructured":"Kozyra EJ, Gohring G, Hickstein DD, Calvo KR, DiNardo CD, Dworzak M et al. Association of unbalanced translocation der(1;7) with germline GATA2 mutations. Blood. 2021;138:2441\u20135.","journal-title":"Blood"},{"key":"1309_CR27","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1111\/bjh.18330","volume":"199","author":"L Kotmayer","year":"2022","unstructured":"Kotmayer L, Romero-Moya D, Marin-Bejar O, Kozyra E, Catala A, Bigas A et al. GATA2 deficiency and MDS\/AML: Experimental strategies for disease modelling and future therapeutic prospects. Br J Haematol. 2022;199:482\u201395.","journal-title":"Br J Haematol"},{"key":"1309_CR28","doi-asserted-by":"publisher","first-page":"276","DOI":"10.3324\/haematol.2013.090217","volume":"99","author":"RR West","year":"2014","unstructured":"West RR, Hsu AP, Holland SM, Cuellar-Rodriguez J, Hickstein DD. Acquired ASXL1 mutations are common in patients with inherited GATA2 mutations and correlate with myeloid transformation. Haematologica. 2014;99:276\u201381.","journal-title":"Haematologica"},{"key":"1309_CR29","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1182\/bloodadvances.2021005065","volume":"6","author":"RR West","year":"2022","unstructured":"West RR, Calvo KR, Embree LJ, Wang W, Tuschong LM, Bauer TR et al. ASXL1 and STAG2 are common mutations in GATA2 deficiency patients with bone marrow disease and myelodysplastic syndrome. Blood Adv. 2022;6:793\u2013807.","journal-title":"Blood Adv"},{"key":"1309_CR30","doi-asserted-by":"publisher","first-page":"e398","DOI":"10.3324\/haematol.2015.127092","volume":"100","author":"X Wang","year":"2015","unstructured":"Wang X, Muramatsu H, Okuno Y, Sakaguchi H, Yoshida K, Kawashima N et al. GATA2 and secondary mutations in familial myelodysplastic syndromes and pediatric myeloid malignancies. Haematologica. 2015;100:e398\u2013401.","journal-title":"Haematologica"},{"key":"1309_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2022.801810","volume":"10","author":"G Ovsyannikova","year":"2022","unstructured":"Ovsyannikova G, Pavlova A, Deordieva E, Raykina E, Pshonkin A, Maschan A et al. Single Center Experience With Pediatric Patients With GATA2 Deficiency. Front Pediatr. 2022;10:801810.","journal-title":"Front Pediatr"},{"key":"1309_CR32","first-page":"2551","volume":"108","author":"O Marin-Bejar","year":"2023","unstructured":"Marin-Bejar O, Romero-Moya D, Rodriguez-Ubreva J, Distefano M, Lessi F, Aretini P et al. Epigenome profiling reveals aberrant DNA methylation signature in GATA2 deficiency. Haematologica. 2023;108:2551\u20137.","journal-title":"Haematologica"},{"key":"1309_CR33","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1182\/blood-2018-03-837336","volume":"132","author":"C Wehr","year":"2018","unstructured":"Wehr C, Grotius K, Casadei S, Bleckmann D, Bode SFN, Frye BC et al. A novel disease-causing synonymous exonic mutation in GATA2 affecting RNA splicing. Blood. 2018;132:1211\u20135.","journal-title":"Blood"},{"key":"1309_CR34","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1182\/blood.2022015850","volume":"140","author":"DA Arber","year":"2022","unstructured":"Arber DA, Orazi A, Hasserjian RP, Borowitz MJ, Calvo KR, Kvasnicka HM et al. International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data. Blood. 2022;140:1200\u201328.","journal-title":"Blood"},{"key":"1309_CR35","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.leukres.2018.11.013","volume":"76","author":"LJ McReynolds","year":"2019","unstructured":"McReynolds LJ, Yang Y, Yuen Wong H, Tang J, Zhang Y, Mule MP et al. MDS-associated mutations in germline GATA2 mutated patients with hematologic manifestations. Leuk Res. 2019;76:70\u20135.","journal-title":"Leuk Res"},{"key":"1309_CR36","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/nature19057","volume":"536","author":"M Lek","year":"2016","unstructured":"Lek M, Karczewski KJ, Minikel EV, Samocha KE, Banks E, Fennell T et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature. 2016;536:285\u201391.","journal-title":"Nature"},{"key":"1309_CR37","doi-asserted-by":"publisher","first-page":"3766","DOI":"10.1182\/blood-2010-04-280313","volume":"116","author":"G Gohring","year":"2010","unstructured":"Gohring G, Michalova K, Beverloo HB, Betts D, Harbott J, Haas OA et al. Complex karyotype newly defined: the strongest prognostic factor in advanced childhood myelodysplastic syndrome. Blood. 2010;116:3766\u20139.","journal-title":"Blood"},{"key":"1309_CR38","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405\u201324.","journal-title":"Genet Med"},{"key":"1309_CR39","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1038\/gim.2017.37","volume":"19","author":"K Nykamp","year":"2017","unstructured":"Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY et al. Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria. Genet Med. 2017;19:1105\u201317.","journal-title":"Genet Med"},{"key":"1309_CR40","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/ng.2892","volume":"46","author":"M Kircher","year":"2014","unstructured":"Kircher M, Witten DM, Jain P, O\u2019Roak BJ, Cooper GM, Shendure J. A general framework for estimating the relative pathogenicity of human genetic variants. Nat Genet. 2014;46:310\u20135.","journal-title":"Nat Genet"},{"key":"1309_CR41","doi-asserted-by":"publisher","first-page":"D886","DOI":"10.1093\/nar\/gky1016","volume":"47","author":"P Rentzsch","year":"2019","unstructured":"Rentzsch P, Witten D, Cooper GM, Shendure J, Kircher M. CADD: predicting the deleteriousness of variants throughout the human genome. Nucleic Acids Res. 2019;47:D886\u2013D94.","journal-title":"Nucleic Acids Res"},{"key":"1309_CR42","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.ajhg.2016.08.016","volume":"99","author":"NM Ioannidis","year":"2016","unstructured":"Ioannidis NM, Rothstein JH, Pejaver V, Middha S, McDonnell SK, Baheti S et al. REVEL: An Ensemble Method for Predicting the Pathogenicity of Rare Missense Variants. Am J Hum Genet. 2016;99:877\u201385.","journal-title":"Am J Hum Genet"},{"key":"1309_CR43","doi-asserted-by":"publisher","first-page":"e229","DOI":"10.1093\/rheumatology\/keaa913","volume":"60","author":"L Sun","year":"2021","unstructured":"Sun L, Xu N, Shen M, Wang R, Sun Y, Zhuang J et al. GATA2 mutation with recurrent haemophagocytic lymphohistiocytosis and panniculitis: a case report. Rheumatol (Oxf). 2021;60:e229\u2013e31.","journal-title":"Rheumatol (Oxf)"},{"key":"1309_CR44","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1182\/blood.2020005538","volume":"136","author":"LFB Catto","year":"2020","unstructured":"Catto LFB, Borges G, Pinto AL, Cle DV, Chahud F, Santana BA et al. Somatic genetic rescue in hematopoietic cells in GATA2 deficiency. Blood. 2020;136:1002\u20135.","journal-title":"Blood"},{"key":"1309_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2011-12-7-r68","volume":"12","author":"MN Bainbridge","year":"2011","unstructured":"Bainbridge MN, Wang M, Wu Y, Newsham I, Muzny DM, Jefferies JL et al. Targeted enrichment beyond the consensus coding DNA sequence exome reveals exons with higher variant densities. Genome Biol. 2011;12:R68.","journal-title":"Genome Biol"},{"key":"1309_CR46","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/nrg3031","volume":"12","author":"MJ Bamshad","year":"2011","unstructured":"Bamshad MJ, Ng SB, Bigham AW, Tabor HK, Emond MJ, Nickerson DA et al. Exome sequencing as a tool for Mendelian disease gene discovery. Nat Rev Genet. 2011;12:745\u201355.","journal-title":"Nat Rev Genet"},{"key":"1309_CR47","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/s42003-022-03316-w","volume":"5","author":"A Hasegawa","year":"2022","unstructured":"Hasegawa A, Hayasaka Y, Morita M, Takenaka Y, Hosaka Y, Hirano I et al. Heterozygous variants in GATA2 contribute to DCML deficiency in mice by disrupting tandem protein binding. Commun Biol. 2022;5:376.","journal-title":"Commun Biol"},{"key":"1309_CR48","doi-asserted-by":"publisher","unstructured":"Largeaud L, Fregona V, Jamrog LA, Hamelle C, Dufrechou S, Prade N, et al. Loss of HSC stemness identity is associated with exhaustion and hyporesponsiveness in GATA2 deficiency syndrome. bioRxiv. 2023. https:\/\/doi.org\/10.1101\/2023.08.07.551811.","DOI":"10.1101\/2023.08.07.551811"},{"key":"1309_CR49","doi-asserted-by":"publisher","unstructured":"Fernandez-Orth J, Koyunlar C, Weiss JM, Gioacchino E, de Looper H, Andrieux G, et al. Hematological phenotypes in GATA2 deficiency syndrome arise from secondary injuries and maladaptation to proliferation. bioRxiv. 2024. https:\/\/doi.org\/10.1101\/2024.09.24.614663.","DOI":"10.1101\/2024.09.24.614663"},{"key":"1309_CR50","doi-asserted-by":"publisher","first-page":"2962","DOI":"10.1182\/bloodadvances.2019000644","volume":"3","author":"X Luo","year":"2019","unstructured":"Luo X, Feurstein S, Mohan S, Porter CC, Jackson SA, Keel S et al. ClinGen Myeloid Malignancy Variant Curation Expert Panel recommendations for germline RUNX1 variants. Blood Adv. 2019;3:2962\u201379.","journal-title":"Blood Adv"},{"key":"1309_CR51","doi-asserted-by":"publisher","first-page":"870","DOI":"10.3324\/haematol.2018.214221","volume":"105","author":"D Wu","year":"2020","unstructured":"Wu D, Luo X, Feurstein S, Kesserwan C, Mohan S, Pineda-Alvarez DE et al. How I curate: applying American Society of Hematology-Clinical Genome Resource Myeloid Malignancy Variant Curation Expert Panel rules for RUNX1 variant curation for germline predisposition to myeloid malignancies. Haematologica. 2020;105:870\u201387.","journal-title":"Haematologica"}],"container-title":["Blood Cancer Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41408-025-01309-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41408-025-01309-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41408-025-01309-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T08:03:38Z","timestamp":1759133018000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41408-025-01309-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,15]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1309"],"URL":"https:\/\/doi.org\/10.1038\/s41408-025-01309-6","relation":{},"ISSN":["2044-5385"],"issn-type":[{"value":"2044-5385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,15]]},"assertion":[{"value":"13 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Claudia Wehr: honoraria from Takeda, Grifols, Jazz Pharmaceuticals and MSD (not related to the work in this manuscript). Marcin Wlodarski: Retro bio, Guidepoint and OLG Research & Consulting (consultancy) not related to the work in this manuscript.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"121"}}